The burgeoning trend in diabetes care is undoubtedly centered around GLP-1 therapies, and BrightMeds is spearheading this movement . These groundbreaking drugs, initially developed for treating type 2 diabetes, are now increasingly prescribed – or being explored – for their remarkable ability to promote slimming and improve general health. Brig